IP Library Assignment 060161/0046
Patent Assignment
Reel/Frame 060161/0046

Change of Name

Recorded: 2022-06-10 Pages: 11
Assignor
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Properties (24)
Peptides Comprising an Epitope of the Wilms Tumor Gene Product
Patent: 7,939,627 →
Application: 12/095,418 →
Publication: US 2010/0062010
Dimerized Peptide
Patent: 8,242,084 →
Application: 12/795,187 →
Publication: US 2010/0292164
Method for Cancer Immunotherapy
Patent: 8,575,308 →
Application: 13/053,996 →
Publication: US 2011/0229506
Method for Cancer Immunotherapy
Patent: 9,273,148 →
Application: 14/022,413 →
Publication: US 2014/0046036
WT1 Antigen Peptide Conjugate Vaccine
Patent: 9,181,302 →
Application: 14/549,091 →
Publication: US 2015/0080321
WT1 Antigen Peptide Conjugate Vaccine
Patent: 9,248,173 →
Application: 14/706,772 →
Publication: US 2015/0238587
Conjugate Vaccine Using Trimming Function of ERAP1
Application: 14/780,241 →
Publication: US 2016/0045582
Method for Cancer Immunotherapy
Patent: 9,765,114 →
Application: 15/054,805 →
Publication: US 2016/0168197
Combination Use of WT1 Antigen Peptide and Immunomodulator
Application: 15/575,162 →
Publication: US 2018/0140691
WT1 Antigen Peptide Conjugate Vaccine
Application: 16/163,067 →
Publication: US 2019/0030149
WT1 Helper Peptides and Combinations of WT1 Helper Peptide and Conjugate of Cancer Antigen Peptides
Application: 16/464,950 →
Publication: US 2020/0016255
Optically Active Azabicyclo Ring Derivative
Application: 16/629,739 →
Publication: US 2021/0338668
Conjugate Vaccine Using Trimming Function of ERAP1
Application: 16/785,958 →
Publication: US 2020/0171136
Dihydrochromene Derivatives
Application: 16/944,482 →
Publication: US 2021/0002290
Optically Active Crosslinked Cyclic Secondary Amine Derivative
Application: 17/042,479 →
Publication: US 2021/0024547
Pyridazinone Derivative
Application: 17/260,831 →
Publication: US 2022/0347175
Optically Active Bridged Piperidine Derivative
Application: 17/265,920 →
Publication: US 2021/0198283
Injectable Composition
Application: 17/279,807 →
Publication: US 2021/0338587
Composition for Preventing or Treating Benign Tumor
Application: 17/282,172 →
Publication: US 2022/0008528
Cycloalkylurea Derivative
Application: 17/526,722 →
Publication: US 2022/0081441
Cycloalkylurea Derivative
Application: 17/610,291 →
Publication: US 2023/0088694
Benzisoxazole Derivative
Application: 17/623,527 →
Publication: US 2023/0202991
Benzisoxazole Derivative
Application: 17/701,539 →
Publication: US 2022/0289694
Crosslinked Optically Active Secondary Amine Derivative
Application: 17/763,265 →
Publication: US 2022/0380365
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 30, 2008
From: NISHIHARA, TOSHIO; GOTOH, MASASHI
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.; CHUGAI SEIYAKU KABUSHIKI KAISHA; DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 021020/0343 →
Change of Name Oct 10, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033969/0194 →
Assignment of Partial Rights May 4, 2015
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 035571/0862 →
Assignment of Assignor's Interest May 4, 2015
From: LI, CHIANG JIA; BAN, HITOSHI; NISHIO, YUKIHIRO; GOTO, MASASHI
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 035552/0990 →
Assignment of Assignor's Interest Sep 25, 2015
From: BAN, HITOSHI; NISHIO, YUKIHIRO; GOTO, MASASHI; TAKANASHI, YOSUKE
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 036659/0411 →
Assignment of Assignor's Interest Apr 25, 2016
From: CHUGAI SEIYAKU KABUSHIKI KAISHA
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 038364/0495 →
Assignment of Assignor's Interest Jul 18, 2016
From: CHUGAI SEIYAKU KABUSHIKI KAISHA
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 039176/0080 →
Assignment of Assignor's Interest Nov 17, 2017
From: TAKASU, HIDEO; NAKAMURA, MEGUMI; GOTO, MASASHI; SUGINOBE, NATSUKO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 044163/0476 →
Assignment of Assignor's Interest May 29, 2019
From: BAN, HITOSHI; GOTO, MASASHI; TAKANASHI, YOSUKE
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 049308/0264 →
Assignment of Assignor's Interest Apr 29, 2020
From: KAMIOKA, SEIJI; BAN, HITOSHI; SHIMADA, NAOAKI; HIROSE, WATARU
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 052523/0286 →
Assignment of Assignor's Interest Sep 28, 2020
From: KAMIOKA, SEIJI; SHIMADA, NAOAKI; HIROSE, WATARU; BAN, HITOSHI
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 053902/0666 →
Assignment of Assignor's Interest Jan 15, 2021
From: NISHIDA, TOMOAKI; UEMACHI, HIRO; IWATA, MASATO; SHIBATA, HAJIME
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 054935/0328 →
Assignment of Assignor's Interest Mar 25, 2021
From: MORITA, AKIHIRO; TSUZUKU, TAKUMA; YOSHINAGA, YUKO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 055717/0171 →
Assignment of Assignor's Interest Apr 1, 2021
From: KAMIOKA, SEIJI; SHIMADA, NAOAKI; BAN, HITOSHI; YAMAZAKI, KAZUTO
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 055800/0844 →
Assignment of Assignor's Interest Apr 1, 2021
From: SUGIYAMA, HARUO
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.; SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 055807/0161 →
Assignment of Assignor's Interest Sep 4, 2025
From: SUMITOMO PHARMA CO., LTD.
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 072160/0981 →